CorMedix, Inc. (CRMD)
6.78
-0.23
(-3.28%)
USD |
NASDAQ |
Jan 16, 16:00
6.75
-0.03
(-0.44%)
After-Hours: 20:00
CorMedix Market Cap: 534.19M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.421B |
| Pfizer Inc. | 145.84B |
| Arcutis Biotherapeutics, Inc. | 3.166B |
| ANI Pharmaceuticals, Inc. | 1.905B |
| Alkermes Plc | 5.223B |
Market Cap Related Metrics
| PE Ratio | 3.302 |
| PS Ratio | 2.283 |
| Price to Book Value | 1.428 |
| Price to Free Cash Flow | 6.574 |
| Price | 6.78 |
| Earnings Yield | 30.28% |
| Operating PE Ratio | 4.706 |
| Normalized PE Ratio | 3.311 |